SBSB
CVS icon

Sullivan, Bruyette, Speros & Blaney’s CVS Health CVS Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$551K Buy
7,320
+1,670
+30% +$122K 0.02% 173
2020
Q4 		$386K Sell
5,650
-1,054
-16% -$68.6K 0.02% 193
2020
Q3 		$392K Sell
6,704
-1,039
-13% -$64.7K 0.02% 168
2020
Q2 		$503K Buy
7,743
+1,083
+16% +$68.2K 0.03% 135
2020
Q1 		$395K Sell
6,660
-93
-1% -$6.21K 0.03% 141
2019
Q4 		$502K Buy
6,753
+266
+4% +$18.7K 0.03% 140
2019
Q3 		$409K Buy
6,487
+11
+0.2% +$652 0.02% 152
2019
Q2 		$353K Buy
6,476
+228
+4% +$12.3K 0.02% 161
2019
Q1 		$337K Sell
6,248
-117
-2% -$7.22K 0.02% 155
2018
Q4 		$417K Buy
6,365
+1,202
+23% +$89.7K 0.03% 123
2018
Q3 		$406K Buy
5,163
+96
+2% +$6.86K 0.04% 111
2018
Q2 		$326K Buy
5,067
+3
+0.1% +$198 0.03% 128
2018
Q1 		$315K Buy
5,064
+103
+2% +$7.39K 0.03% 126
2017
Q4 		$360K Sell
4,961
-331
-6% -$24.1K 0.03% 118
2017
Q3 		$430K Sell
5,292
-659
-11% -$52.1K 0.04% 96
2017
Q2 		$479K Sell
5,951
-349
-6% -$27.6K 0.05% 88
2017
Q1 		$495K Sell
6,300
-778
-11% -$62.1K 0.05% 82
2016
Q4 		$559K Sell
7,078
-1,035
-13% -$83.7K 0.06% 78
2016
Q3 		$722K Buy
8,113
+188
+2% +$17.7K 0.07% 57
2016
Q2 		$759K Buy
+7,925
New +$790K 0.08% 53

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's CVS Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its CVS Health (CVS) stake by 30% in Q1 2021, buying an estimated $122K and bringing the position to 7,320 shares worth $551K. The position accounts for 0.02% of the portfolio, ranked #173.

Sullivan, Bruyette, Speros & Blaney first reported a position in CVS in Q2 2016 and has held it in 20 quarters since. The position peaked at $759K in Q2 2016. 2,033 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 7,320 shares of CVS Health worth $551K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney bought 1,670 CVS Health shares in Q1 2021, an estimated $122K.
  • CVS Health made up 0.02% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #173 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in CVS Health in Q2 2016 and has held it in 20 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's CVS Health position peaked at $759K in Q2 2016.
  • 2,033 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.